Nilo Therapeutics Raises $101M in Series A

Nilo Therapeutics has successfully raised $101M in a Series A at a $400M valuation led by The Column Group, DCVC Bio, Lux Capital, Gates Foundation.

Company Overview

Nilo Therapeutics is a Biotech company headquartered in New York, NY, founded in 2025 with 30+ employees.

Developing therapies targeting neural circuits for immune disease regulation

Fundraising Details

Amount Raised: $101M
Round Type: Series A
Valuation: $400M
Date: 2025-10-08
Investors: The Column Group, DCVC Bio, Lux Capital, Gates Foundation

About Nilo Therapeutics

Developing therapies targeting neural circuits for immune disease regulation The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: New York, NY
Founded: 2025
Team Size: 30+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Nilo Therapeutics's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Nilo Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $400M valuation marks an important milestone for Nilo Therapeutics, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Nilo Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-10-08. For more information about Nilo Therapeutics, visit their headquarters at New York, NY.